Retrospective Analysis of Efficacy, Safety, Prognostic Parameters, and Quality of Life Factors in Topical Immunotherapy of Alopecia Areata with Diphenylcyclopropenone
January 2021
in “
Online Publication Service of Würzburg University (Würzburg University)
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study examines the use of diphenylcyclopropenone in treating alopecia areata patients at the University Hospital Würzburg and investigates how the treatment affects patients' quality of life.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This retrospective analysis examined the treatment of patients with Alopecia areata using Diphenylcyclopropenon at the Clinic and Polyclinic for Dermatology, Venereology, and Allergology at the University Hospital Würzburg. The study focused on the effectiveness and safety of the treatment, as well as prognostic parameters and factors affecting the quality of life influenced by the treatment. The analysis provided insights into how the topical immunotherapy impacted patients' lives, although specific numerical data or outcomes were not detailed in the summary.
